Literature DB >> 18199709

Equol status modifies the association of soy intake and mammographic density in a sample of postmenopausal women.

Barbara J Fuhrman1, Barbara E Teter, Maddalena Barba, Celia Byrne, Adalberto Cavalleri, Brydon J Grant, Peter J Horvath, Daniele Morelli, Elisabetta Venturelli, Paola C Muti.   

Abstract

Only 30% to 50% of people produce the daidzein-metabolite equol after eating soy. We conducted a cross-sectional study of the associations between equol status, intake of soy foods, and mammographic density in a sample of postmenopausal women recruited at a radiology clinic near Buffalo, New York. Participants were 48 to 82 years old, had no history of cancer or breast reduction/augmentation, and no recent use of antibiotics or hormones. Percent density was measured by computer-assisted analysis of digitized images of craniocaudal films. Equol status was assessed using a soy-challenge protocol and usual soy intake by questionnaire. General linear models were used to assess independent and joint effects of equol status and intake of soy on multivariate adjusted percent density (covariates included age, body mass index, parity, age at first birth, and ever use of combined hormone therapy). Of 325 enrolled, 232 (71%) participants completed study assessments and are included in the present analysis. Mean percent density was 34% (+/-18%). Seventy-five (30%) participants were producers of equol. Forty-three (19%) participants reported regularly eating >1 soy food or supplement/wk. There were no significant independent associations of equol status or soy intake with percent density, but the interaction between these factors was significant (P < 0.01). Among equol producers, those with weekly soy intake had lower percent density (30.7% in weekly consumers of soy versus 38.9% in others; P = 0.08); among nonproducers, weekly soy intake was associated with higher percent density (37.5% in weekly soy consumers versus 30.7% in others; P = 0.03). Results suggest that equol producers and nonproducers may experience different effects of dietary soy on breast tissue.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18199709     DOI: 10.1158/1055-9965.EPI-07-0193

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  15 in total

Review 1.  Emerging research on equol and cancer.

Authors:  Johanna W Lampe
Journal:  J Nutr       Date:  2010-05-26       Impact factor: 4.798

Review 2.  Effects of isoflavones on breast tissue and the thyroid hormone system in humans: a comprehensive safety evaluation.

Authors:  S Hüser; S Guth; H G Joost; S T Soukup; J Köhrle; L Kreienbrock; P Diel; D W Lachenmeier; G Eisenbrand; G Vollmer; U Nöthlings; D Marko; A Mally; T Grune; L Lehmann; P Steinberg; S E Kulling
Journal:  Arch Toxicol       Date:  2018-08-21       Impact factor: 5.153

Review 3.  Does equol production determine soy endocrine effects?

Authors:  Dana Shor; Thozhukat Sathyapalan; Stephen L Atkin; Natalie J Thatcher
Journal:  Eur J Nutr       Date:  2012-02-25       Impact factor: 5.614

4.  Equol-producing status, isoflavone intake, and breast density in a sample of U.S. Chinese women.

Authors:  Marilyn Tseng; Celia Byrne; Mindy S Kurzer; Carolyn Y Fang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-09       Impact factor: 4.254

5.  Estrogen metabolism and mammographic density in postmenopausal women: a cross-sectional study.

Authors:  Barbara J Fuhrman; Louise A Brinton; Ruth M Pfeiffer; Xia Xu; Timothy D Veenstra; Barbara E Teter; Celia Byrne; Cher M Dallal; Maddalena Barba; Paola C Muti; Gretchen L Gierach
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-06-26       Impact factor: 4.254

6.  Impact of perinatal exposure to equol enantiomers on reproductive development in rodents.

Authors:  Nadine M Brown; Stephanie L Lindley; David P Witte; Kenneth D R Setchell
Journal:  Reprod Toxicol       Date:  2011-05-20       Impact factor: 3.143

7.  S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.

Authors:  Mandeep K Virk-Baker; Stephen Barnes; Helen Krontiras; Tim R Nagy
Journal:  Nutr Res       Date:  2013-12-18       Impact factor: 3.315

8.  Plasma equol concentration is not associated with breast cancer and fibrocystic breast conditions among women in Shanghai, China.

Authors:  Charlotte Atkinson; Roberta M Ray; Wenjin Li; Ming-Gang Lin; Dao Li Gao; Jackilen Shannon; Helge Stalsberg; Peggy L Porter; Cara L Frankenfeld; Kristiina Wähälä; David B Thomas; Johanna W Lampe
Journal:  Nutr Res       Date:  2016-03-30       Impact factor: 3.315

9.  Coffee intake and risk of type 2 diabetes: the Multiethnic Cohort.

Authors:  Taisha Doo; Yukiko Morimoto; Astrid Steinbrecher; Laurence N Kolonel; Gertraud Maskarinec
Journal:  Public Health Nutr       Date:  2013-02-27       Impact factor: 4.022

10.  Is equol the key to the efficacy of soy foods?

Authors:  Johanna W Lampe
Journal:  Am J Clin Nutr       Date:  2009-04-08       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.